Navigation Links
Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients

lts to differ materially from those projected. Many of these factors are beyond the company's ability to control or predict. Important factors that may cause actual results to differ materially and could impact the company and the statements contained in this news release can be found in the company's filings with the Securities and Exchange Commission, including quarterly reports on Form 10-Q, current reports on Form 8-K and annual reports on Form 10-K. For forward-looking statements in this news release, the company claims the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. The company assumes no obligation to update or supplement any forward-looking statements whether as a result of new information, future events or otherwise.

About Bristol-Myers Squibb

Bristol-Myers Squibb is dedicated to the discovery, development and exhaustive exploration of innovative cancer fighting therapies designed to extend and enhance the lives of patients living with cancer. More than 40 years ago, Bristol-Myers Squibb built a unified vision for the future of cancer treatment. With expertise, dedication and resolve, that vision led to the development of a diverse global portfolio of anti-cancer therapies that are an important cornerstone of care today. Hundreds of scientists at Bristol- Myers Squibb's Pharmaceutical Research Institute are studying ways to improve current cancer treatments and identify better, more effective medicines for the future.

Bristol-Myers Squibb is a global pharmaceutical and related health care products company whose mission is to extend and enhance human life.

This press release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995, regarding product development. Such forward-looking statements are based on current expectations and involve inherent risks and uncertainties, including factor
'"/>




Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
2. YM BioSciences Reports AeroLEF Randomized Phase IIb Trial Meets Primary Endpoint in Patients with Post-Surgical Pain
3. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
4. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
5. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Post Your Comments:
(Date:3/26/2015)... British Columbia, March 26, 2015  OncoGenex Pharmaceuticals, ... summary of clinical developments and announced fourth quarter ... Clinical Developments and Anticipated Near-term MilestonesCustirsen ... Teva agreed to negotiate the termination of their ... of the final termination agreement are ongoing. ...
(Date:3/26/2015)... 2015 Over-the-counter healthcare costs can be ... a new survey of store brand over-the-counter products ... cold to diabetes, can offer significant savings for ... the Private Label Manufacturers Association, assembled a market ... those essential for treatment of pre-diabetes and diabetes. ...
(Date:3/26/2015)... PLEASANTON, Calif. , March 26, 2015  Desert ... the Nation five times , is the first ... System in its emergency department to help clinicians prevent ... in Victorville, Calif. , is a ... and bariatric patients.  Using the Leaf Patient Monitor in ...
Breaking Medicine Technology:OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 2OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 3OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 4OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 5OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 6OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 7OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 8Consumers can keep over-the-counter medicine affordable by using store brands 2Desert Valley Medical Center First to Use Leaf Healthcare Patient Wearable Technology in its ED as Part of Hospital-wide Deployment 2Desert Valley Medical Center First to Use Leaf Healthcare Patient Wearable Technology in its ED as Part of Hospital-wide Deployment 3
... , ATLANTA and STOCKHOLM , ... (1907-1986), inventor of the radiosurgical instrument that bears his ... (Solna, Sweden ), performed the world,s first ... location of the first Leksell Gamma Knife. Karolinska University ...
... April 23 Yesterday, T he Lancet ... once-daily human GLP-1 analog, Victoza® (liraglutide [rDNA] injection) with a DPP-4 ... reductions in A1C, fasting plasma glucose (FPG), and body weight than ... , , ...
Cached Medicine Technology:Karolinska University Hospital Acquires Leksell Gamma Knife Perfexion to Expand Radiosurgery Versatility, Efficiency in Brain Cancer Therapy 2Karolinska University Hospital Acquires Leksell Gamma Knife Perfexion to Expand Radiosurgery Versatility, Efficiency in Brain Cancer Therapy 3The Lancet publishes new data demonstrating superior efficacy of Victoza(R) (liraglutide [rDNA] injection) compared to Januvia(R) (sitagliptin) in the treatment of type 2 diabetes 2The Lancet publishes new data demonstrating superior efficacy of Victoza(R) (liraglutide [rDNA] injection) compared to Januvia(R) (sitagliptin) in the treatment of type 2 diabetes 3The Lancet publishes new data demonstrating superior efficacy of Victoza(R) (liraglutide [rDNA] injection) compared to Januvia(R) (sitagliptin) in the treatment of type 2 diabetes 4The Lancet publishes new data demonstrating superior efficacy of Victoza(R) (liraglutide [rDNA] injection) compared to Januvia(R) (sitagliptin) in the treatment of type 2 diabetes 5The Lancet publishes new data demonstrating superior efficacy of Victoza(R) (liraglutide [rDNA] injection) compared to Januvia(R) (sitagliptin) in the treatment of type 2 diabetes 6
(Date:3/26/2015)... Let’s not lose focus of why people ... traffic magnets. Three out of 4 consumers choose to ... department, according to a Packaged Facts survey. Produce Managers ... to add more fruits and vegetables to their lifestyle. ... April 2. As featured in the Chase’s Calendar of ...
(Date:3/26/2015)... March 26, 2015 UC Davis will ... into the origins of schizophrenia: A Silvio O. Conte ... only 15 such centers in the United States. , ... grant from the National Institutes of Mental Health, which ... novel hypothesis that an origin of schizophrenia may be ...
(Date:3/26/2015)... York, New York (PRWEB) March 26, 2015 ... continue to move forward nationwide, with the issuance ... underway in Pennsylvania and Louisiana. According to an ... federal multidistrict litigation established for Xarelto injury claims ... Louisiana will now allow plaintiffs to file cases ...
(Date:3/26/2015)... DC (PRWEB) March 26, 2015 “The SWEET ... to make healthy options more available and help parents who ... penny tax is a reasonable approach to support public health, ... of this issue for the health of all families,” said ... for Hispanic Health on the introduction of the Sugar-Sweetened Beverage ...
(Date:3/26/2015)... CA (PRWEB) March 26, 2015 Dr. ... are proud to announce expanded offerings for Bay Area ... Francisco Dental Implant Center has long been a top-rated ... expanded its offerings to meet the strong demand by ... our reputation as a top-rated dental implant facility in ...
Breaking Medicine News(10 mins):Health News:UC Davis Receives $10 Million Grant to Establish Center to Study Schizophrenia 2Health News:UC Davis Receives $10 Million Grant to Establish Center to Study Schizophrenia 3Health News:UC Davis Receives $10 Million Grant to Establish Center to Study Schizophrenia 4Health News:Xarelto Lawsuits Move Forward Nationwide, With Issuance of New Court Docs in State, Federal Litigations 2Health News:Xarelto Lawsuits Move Forward Nationwide, With Issuance of New Court Docs in State, Federal Litigations 3Health News:National Alliance for Hispanic Health Statement on Introduction of SWEET Act in 114th Congress 2Health News:Bay Area Dental Implant Specialist, Dr. Alex Rabinovich Announces Regional Educational Strategy 2Health News:Bay Area Dental Implant Specialist, Dr. Alex Rabinovich Announces Regional Educational Strategy 3
... WASHINGTON, Oct. 4 Michael J. Fitzpatrick,executive director ... today,thanked Senator Pete Domenici (New Mexico) for his ... statement followed the senator,s,announcement of his intention to ... 35 years in the nation,s capital, Senator Pete ...
... Oct. 4 Biomoda, Inc. (OTC,Bulletin Board: BMOD) ... lung cancer detection testing and other cancer diagnostic ... of,Southborough, Mass. to provide a range of clinical ... clinical programs. "Averion is a global clinical ...
... The Hartford Center for Geriatric Nursing Excellence in the ... Hartford centers in the nation, have been funded for ... have the most recent evidence-based guidelines for caring for ... Centers of Geriatric Nursing Excellence, which will form the ...
... National IPF Awareness Week on Capitol Hill Drives,Efforts ... SAN JOSE, Calif., Oct. 4 The ... success of its fifth,annual National IPF Awareness Week, ... about the critical need to fund new research ...
... N.J., Oct. 4 The following is a,statement regarding ... health information online:, It is encouraging that companies ... personal health record (PHR) products and systems,that people can ... more companies will follow suit. Having ready access to ...
... MedImmune, Inc. today announced results from two important studies ... (IDSA) 45th Annual Meeting adding to the body of ... a viral pathogen that produces annual outbreaks usually between ... in healthy children, it can prove to be a ...
Cached Medicine News:Health News:Biomoda and Averion International Announce Agreement for Clinical Services 2Health News:CPF Urges Congress to Increase Funding for IPF Research in 2009 Federal Budget 2Health News:CPF Urges Congress to Increase Funding for IPF Research in 2009 Federal Budget 3Health News:CPF Urges Congress to Increase Funding for IPF Research in 2009 Federal Budget 4Health News:Statement Regarding Microsoft's Announcement of New Services to Help People Store Their Health Information Online 2Health News:Medimmune announces phase 2 safety data for anti-RSV antibody and national RSV surveillance results 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: